Project: nciOncology
Class Radiosensitizing_Agent

Concrete Class Extends 

        Adjuvant

 

Direct Instances:

None

 

Direct Subclasses:

1. Mitolactol
2. Nolatrexed
3. Carbogen
4. Hyperbaric_Oxygen
5. Razoxane
6. Desmethylmisonidazole
7. RSR-13
8. Cisplatin
9. Dipyridamole
10. Motexafin_Gadolinium
11. Etanidazole
12. N-Methylformamide
13. Boronophenylalanine-Fructose_Complex
14. Caffeine
15. Misonidazole
16. Neu-Sensamide
17. Perflubron
18. Cladribine
19. Lonidamine
20. Pimonidazole
21. Tirapazamine
22. Bromodeoxyuridine
23. Declopramide

Template Slots
Slot name	Documentation	Type	Allowed Values/Classes	Cardinality	Default
rChemical_or_Drug_Has_Biochemical_Class_or_Structure		Instance	Chemicals_and_Drugs_Kind	0:*
rChemical_or_Drug_Has_Target_Protein		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Target_Anatomy		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Affects_Cell_Type_or_Tissue		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Has_Source		Instance	Organism_Kind	0:*
rChemical_or_Drug_Has_Target_Organism		Instance	Organism_Kind	0:*
rChemical_or_Drug_Plays_Role_in_Biological_Process		Instance	Biological_Process_Kind	0:*
rChemical_or_Drug_Has_Biochemical_Function		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Receptor		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Associated_Pathology		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_FDA_Approved_for_Disease		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_is_Part_of_Chemical_or_Drug		Instance	Chemicals_and_Drugs_Kind	0:*

Own Slots
Slot name	Documentation	Type	Value	Cardinality
:OWL-DISJOINT-CLASSES		Instance

Return to class hierarchy